EUVIMEDEUVIMED entdecken
Fallbericht

Identification of Wandering Masses and Tumor Heterogeneity on 68 Ga-DOTATATE and 18 F-FDG PET/CT in Metastatic Grade II Neuroendocrine Tumor with Increased Somatostatin Receptor Expression After Combined Chemotherapy and PRRT

Parth Baberwal, Rahul Parghane, Sandip Basu

Journal of Nuclear Medicine Technology · 2024

DOI: 10.2967/jnmt.123.267286 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Nuclear Medicine Technology, 2024. Verfasst von Parth Baberwal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Mumbai, India, and Homi Bhabha National Institute, Mumbai, I…. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Organometallic Compounds, Receptors, Somatostatin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsOrganometallic CompoundsReceptors, SomatostatinFemaleHumansMaleMiddle AgedFluorodeoxyglucose F18Gene Expression Regulation, NeoplasticNeoplasm GradingNeoplasm MetastasisPositron Emission Tomography Computed TomographyReceptors, Peptide

Stichwörter der Autor:innen

18F-FDG68Ga-DOTATATEPET/CTneuroendocrine tumorpeptide receptor radionuclide therapysomatostatin receptor

Substanzen

Fluorodeoxyglucose F18gallium Ga 68 dotatateOrganometallic CompoundsReceptors, PeptideReceptors, Somatostatin

Autor:innen und Institutionen

  • Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Mumbai, India, and Homi Bhabha National Institute, Mumbai, India.
  • Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Mumbai, India, and Homi Bhabha National Institute, Mumbai, India drsanb@yahoo.com.

Zitieren

APA

Baberwal, P., Parghane, R., & Basu, S. (2024). Identification of Wandering Masses and Tumor Heterogeneity on 68 Ga-DOTATATE and 18 F-FDG PET/CT in Metastatic Grade II Neuroendocrine Tumor with Increased Somatostatin Receptor Expression After Combined Chemotherapy and PRRT. Journal of Nuclear Medicine Technology. https://doi.org/10.2967/jnmt.123.267286

Vancouver

Baberwal P, Parghane R, Basu S. Identification of Wandering Masses and Tumor Heterogeneity on 68 Ga-DOTATATE and 18 F-FDG PET/CT in Metastatic Grade II Neuroendocrine Tumor with Increased Somatostatin Receptor Expression After Combined Chemotherapy and PRRT. Journal of Nuclear Medicine Technology. 2024. doi:10.2967/jnmt.123.267286

BibTeX
@article{Baberwal2024,
  author = {Baberwal, Parth and Parghane, Rahul and Basu, Sandip},
  title = {Identification of Wandering Masses and Tumor Heterogeneity on 68 Ga-DOTATATE and 18 F-FDG PET/CT in Metastatic Grade II Neuroendocrine Tumor with Increased Somatostatin Receptor Expression After Combined Chemotherapy and PRRT},
  journal = {Journal of Nuclear Medicine Technology},
  year = {2024},
  doi = {10.2967/jnmt.123.267286}
}
Kostenlos starten →